Semaglutide side effects in the UK
Semaglutide side effects are usually discussed as if every brand and route behaves the same way. In practice, the ingredient is the common thread, but the route, dose step and clinical context still matter. A useful UK guide starts with the common effects, then separates the points that change when the route is Wegovy, Ozempic or Rybelsus.
The side effects most people hear about first
Stomach symptoms
Nausea, vomiting, diarrhoea, constipation and stomach pain are the side effects most often discussed on public semaglutide pages and in patient guidance.
Dose changes matter
Side effects often become more noticeable when treatment starts or when the dose moves up, which is why route and dose step should stay in the same conversation.
Route still matters
A daily tablet route and a weekly pen route can feel different in practice, even when the active ingredient is still semaglutide.
Sources: NHS semaglutide guidance, Wegovy SmPC, Ozempic SmPC, Rybelsus SmPC.
The 2026 MHRA eye warning belongs in the picture
In February 2026, the MHRA updated product information for semaglutide to reflect the very rare risk of non-arteritic anterior ischemic optic neuropathy (NAION). That warning applies across semaglutide brands, so it should not be treated as a Wegovy-only or diabetes-only footnote.
That does not make semaglutide unsuitable by default. It does mean sudden changes in vision are not something to sit on while waiting for the next routine follow-up.
When the next step should be prompt, not passive
| Problem | Why it matters | Practical response |
|---|---|---|
| Persistent vomiting or diarrhoea | Fluid loss can build quickly and may make the route harder to tolerate safely. | Ask the provider or GP for advice rather than pushing through repeated dose days. |
| Severe stomach pain | Severe pain belongs in a different category from mild settling-in nausea. | Do not treat severe or escalating pain as routine treatment adjustment. |
| Sudden change in vision | This is the red-flag symptom tied to the MHRA NAION update. | Seek urgent medical advice rather than waiting for the next provider message reply. |
| Symptoms of low blood sugar | This is more likely when semaglutide sits beside certain diabetes medicines. | Use clinical advice promptly, especially if other glucose-lowering medicines are involved. |
How the side-effect conversation changes by route
Wegovy
The weight-management route usually sits inside dose progression, private provider review and weekly-injection handling advice.
Ozempic
Ozempic often appears in crossover content, so it is worth checking whether a page is really explaining Ozempic or really pointing you toward Wegovy.
Rybelsus
The daily oral route changes the rhythm of the conversation, because timing, empty-stomach use and tablet-specific instructions become part of the practical picture.
Keep these pages open alongside the side-effect question
Semaglutide dosage in the UK
Side effects and dose changes should be read together.
Wegovy
Use the brand page if the real question is about the UK weight-management route.
Rybelsus
Useful when the question is really about oral semaglutide rather than injections.
Browse providers
Check who explains route, delivery and follow-up clearly before you rely on their wording.